// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Cardiopulmonary excercise testing in the diagnosis of chronic unexplained dyspnoea

Sam Roberts - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The role of cardiopulmonary exercise testing in the investigation of complex unexplained breathlessness

Anita Jayadev - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Time-course of changes to intrathoracic pressure induced by CPAP in normal subjects

Michael Apps - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Clinical characteristics of COPD patients with tidal expiratory flow limitation

James Dean - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Effectiveness of approaches to choking due to foreign body airway obstruction - a physiological study

Matthew Pavitt - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The lung function response to exercise challenge testing and eucapnic voluntary hyperpnoea

Stephen How - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Non-invasive assessment of diaphragm contractility using surface mechanomyography in healthy subjects

Manuel Lozano Garca - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Effects of maximal volitional hyperpnoea on single-leg knee-extensor exercise tolerance

Robert Needham - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Who should have a hypoxic challenge test?

Laura Horgan - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Left ventricular volume and wall stress are linked to lung function impairment in COPD

Peter Alter - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Stroke

N/A

Nutritional status and pulmonary and respiratory muscle function in children and young people with cystic fibrosis

Niovi Papalexopoulou - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

N/A

Dynamic hyperinflation and daily physical activity in adults with cystic fibrosis

Daniela Savi - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

N/A

Tryptic activity relates to disease severity and patient mortality in adults with cystic fibrosis

James Reihill - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

N/A

Longitudinal monitoring of lung microstructure with HP gas diffusion-weighted MRI in mild cystic fibrosis children

Ho-Fung Chan - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

N/A

Tolerability and efficacy of Pirfenidone and Nintedanib for patients with IPF in real world clinical practice

Andrew Achaiah - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Pirfenidone

Development of a multivariate model to predict clinical deterioration in pulmonary sarcoidosis

Henry Yung - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Sarcoidosis

N/A

Small airways impairment and air-trapping in patients with chronic hypersensitivity pneumonitis (CHP) of different severity

Matteo Bonini - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Extrinsic allergic alveolitis

N/A

Interstitial pneumonia with autoimmune features: applying novel diagnostic criteria to an existing patient cohort

Helen Hall - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Interstitial Pneumonia with Autoimmune Features

N/A

Echocardiographic parameters in suspected cardiac sarcoidosis patients-the role of speckle tracking strain analysis in the diagnosis of cardiac sarcoidosis

Vasileios Kouranos - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac sarcoidosis

N/A

Global characterisation of routine care interstitial lung disease diagnostic practice

Luca Richeldi - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Interstitial lung disease

N/A

Copyright © 2026. QuantiNova All rights reserved